Skip to main content

Table 3 Patient summary

From: AN69ST membranes adsorb nafamostat mesylate and affect the management of anticoagulant therapy: a retrospective study

Dialysis membrane AN69ST PS P value
Age (years) 69.8 ± 11.4 67.4 ± 19.6 N.S.
Sex (male:female) 13:6 6:5 N.S.
Body weight 58.2 ± 14.6 62.3 ± 16.9 N.S.
SOFA 11.1 ± 4.0 9.5 ± 4.4 N.S.
APACHE II 27.6 ± 10.0 26.9 ± 10.4 N.S.
Mortality 6/19 (32%) 3/11 (27%) N.S.
Sepsis 13/19 (68%) 3/11 (27%) 0.03
QB (mL/min) 95.9 ± 8.9 95.1 ± 15.4 N.S.
QD (mL/h) 934.8 ± 329.6 1422.4 ± 602.5 <0.01
QS (mL/h) 517.7 ± 152.5 602.6 ± 312.8 N.S.
QF (mL/h) 1471.7 ± 414.7 1852.4 ± 662.2 <0.01
  1. Data are the mean and standard deviation or number. For intergroup testing, the Mann-Whitney U test or the χ 2 test was performed at suitable locations. AN69ST polyacrylonitrile (surface treated), PS polysulfone, N.S. not significant, SOFA Sequential Organ Failure Assessment, APACHE II Acute Physiology and Chronic Health Evaluation II score, QB blood pump flow rate, QD dialysate pump flow rate, QF filtration pump flow rate, QS substitution fluid pump flow rate